These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18389090

  • 1. Drospirenone/ethinyl estradiol.
    Rapkin AJ, Sorger SN, Winer SA.
    Drugs Today (Barc); 2008 Feb; 44(2):133-45. PubMed ID: 18389090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Lopez LM, Kaptein AA, Helmerhorst FM.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD006586. PubMed ID: 22336820
    [Abstract] [Full Text] [Related]

  • 4. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug 15; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 5. Drospirenone: a novel progestin.
    Rapkin AJ, Winer SA.
    Expert Opin Pharmacother; 2007 May 15; 8(7):989-99. PubMed ID: 17472544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.
    Marr J, Heinemann K, Kunz M, Rapkin A.
    Int J Gynaecol Obstet; 2011 May 15; 113(2):103-7. PubMed ID: 21338987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW.
    Eur J Contracept Reprod Health Care; 2002 Dec 15; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.